Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Department of Neuropscyhopharmacology, Institute of Chemistry, University of Tartu, Tartu, Estonia.
Mol Psychiatry. 2022 Nov;27(11):4464-4473. doi: 10.1038/s41380-022-01722-4. Epub 2022 Aug 10.
Common variation in the gene encoding the neuron-specific RNA splicing factor RNA Binding Fox-1 Homolog 1 (RBFOX1) has been identified as a risk factor for several psychiatric conditions, and rare genetic variants have been found causal for autism spectrum disorder (ASD). Here, we explored the genetic landscape of RBFOX1 more deeply, integrating evidence from existing and new human studies as well as studies in Rbfox1 knockout mice. Mining existing data from large-scale studies of human common genetic variants, we confirmed gene-based and genome-wide association of RBFOX1 with risk tolerance, major depressive disorder and schizophrenia. Data on six mental disorders revealed copy number losses and gains to be more frequent in ASD cases than in controls. Consistently, RBFOX1 expression appeared decreased in post-mortem frontal and temporal cortices of individuals with ASD and prefrontal cortex of individuals with schizophrenia. Brain-functional MRI studies demonstrated that carriers of a common RBFOX1 variant, rs6500744, displayed increased neural reactivity to emotional stimuli, reduced prefrontal processing during cognitive control, and enhanced fear expression after fear conditioning, going along with increased avoidance behaviour. Investigating Rbfox1 neuron-specific knockout mice allowed us to further specify the role of this gene in behaviour. The model was characterised by pronounced hyperactivity, stereotyped behaviour, impairments in fear acquisition and extinction, reduced social interest, and lack of aggression; it provides excellent construct and face validity as an animal model of ASD. In conclusion, convergent translational evidence shows that common variants in RBFOX1 are associated with a broad spectrum of psychiatric traits and disorders, while rare genetic variation seems to expose to early-onset neurodevelopmental psychiatric disorders with and without developmental delay like ASD, in particular. Studying the pleiotropic nature of RBFOX1 can profoundly enhance our understanding of mental disorder vulnerability.
RBFOX1 基因编码神经元特异性 RNA 剪接因子 RNA 结合 Fox-1 同源物 1(RBFOX1)的常见变异已被确定为多种精神疾病的风险因素,并且已经发现罕见的遗传变异是自闭症谱系障碍(ASD)的病因。在这里,我们更深入地探讨了 RBFOX1 的遗传景观,整合了来自现有和新的人类研究以及 Rbfox1 敲除小鼠研究的证据。挖掘来自人类常见遗传变异大规模研究的现有数据,我们证实了 RBFOX1 与风险容忍度、重度抑郁症和精神分裂症的基于基因和全基因组关联。六种精神障碍的数据显示,与对照组相比,ASD 病例中更频繁地出现 RBFOX1 的拷贝数损失和增益。一致地,ASD 个体死后的额皮质和颞皮质以及精神分裂症个体的前额皮质中 RBFOX1 的表达似乎减少了。大脑功能磁共振成像研究表明,常见 RBFOX1 变体 rs6500744 的携带者对情绪刺激的神经反应增强,认知控制期间前额叶处理减少,恐惧条件作用后恐惧表达增强,同时回避行为增加。研究 Rbfox1 神经元特异性敲除小鼠使我们能够进一步确定该基因在行为中的作用。该模型的特征是明显的多动、刻板行为、恐惧获得和消退受损、社交兴趣减少和缺乏攻击性;它作为 ASD 的动物模型具有极好的结构和面部有效性。总之,趋同的转化证据表明,RBFOX1 的常见变异与广泛的精神特征和障碍有关,而罕见的遗传变异似乎使个体容易患上早期神经发育性精神障碍,包括 ASD,特别是有或没有发育迟缓的个体。研究 RBFOX1 的多效性可以深刻地增强我们对精神障碍易感性的理解。